Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03686566 · ClinicalTrials.gov registry record
Pediatric Solid Tumor Metabolism [A Prospective Study Exploring Metabolism of Solid Tumors in Pediatrics]
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 84
- Enrollment target
NCT03686566 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 84 participants.
The verdict
NCT03686566 has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 84 participants
- Enrollment target
Study Summary
To explore metabolic phenotypes of children with extra-cranial solid tumors and compare these with their histopathological and genetic alterations to discover potential novel biomarkers and therapeutic targets to improve outcomes in children with high risk disease.
Interventions
- DRUG 13C-glucose
- OTHER No glucose infusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2018-11-16 |
| Est. Completion | 2024-01-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03686566
The ClinicalTrials.gov registry entry for NCT03686566 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 13C-glucose is the first listed.
NCT03686566 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03686566 about?
NCT03686566 is a clinical study titled "Pediatric Solid Tumor Metabolism [A Prospective Study Exploring Metabolism of Solid Tumors in Pediatrics]". To explore metabolic phenotypes of children with extra-cranial solid tumors and compare these with their histopathological and genetic alterations to discover potential novel biomarkers and therapeutic targets to improve outcomes in children with high risk disease.
What is the current status of trial NCT03686566?
This trial is currently completed. The enrollment target is 84 participants. The study started on 2018-11-16. Estimated completion is 2024-01-26.
What interventions are being tested in trial NCT03686566?
The interventions under investigation include: 13C-glucose (DRUG), No glucose infusion (OTHER).
Who is sponsoring clinical trial NCT03686566?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.